Potential therapeutic applications of hyaluronan in the lung
- PMID: 18229566
- PMCID: PMC2695200
Potential therapeutic applications of hyaluronan in the lung
Abstract
Hyaluronan (HA), a long-chain polysaccharide, is currently being evaluated as a potential therapeutic agent for a number of inflammatory disorders. The effect of HA on inflammation appears to be related to its molecular size, with larger polysaccharide chains having anti-inflammatory activity and smaller ones having proinflammatory properties. This dichotomous behavior is particularly relevant to the work of our laboratory on an aerosolized preparation of HA to treat pulmonary emphysema. The breakdown of inhaled HA into smaller fragments could possibly induce an inflammatory reaction in the lung that counteracts any beneficial effect. Consequently, the proposed therapeutic use of HA will require development of treatment strategies aimed at minimizing its proinflammatory activity.
Figures



References
-
- Alikhani M, Alikhani Z, Graves DT. Apoptotic effects of LPS on fibroblasts are indirectly mediated through TNFR1. J Dent Res. 2004;83:671–6. - PubMed
-
- Baccarani-Contri M, Vincenzi D, Cicchetti F, et al. Immunocytochemical localization of proteoglycans within normal elastin fibers. Eur J Cell Biol. 1990;53:305–12. - PubMed
-
- Bray BA, Hsu W, Turino GM. Lung hyaluronan as assayed with a biotinylated hyaluronan-binding protein. Exp Lung Res. 1994;20:317–30. - PubMed
-
- Bray BA, Sampson PM, Osman M, et al. Early changes in lung tissue hyaluronan (hyaluronic acid) and hyaluronidase in bleomycin-induced alveolitis in hamsters. Am Rev Respir Dis. 1991;143:284–8. - PubMed
-
- Calkins CM, Heimbach JK, Bensard DD, et al. TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide. J Surg Res. 2001;101:232–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical